This could indicate that Rac1 is a key protein in the lack of treatment responsiveness and/or provides compensatory resistance mechanisms to standard therapy such as chemo- and radiotherapy, as described in other tumor types [4]. This evidence concerns the gene RAC1 and neoplasm.